Executive readout · one minute
Webcast research workspace
Read the call alongside every captured source. 8-K earnings release, 10-Q stay in one workspace.
RXRX
$3.70
+3.35%
RXRX
· Recursion Pharmaceuticals, Inc.
$3.70
+0.12 (+3.35%)
At close · Oct 23
Return incl. dividend (before tax)
Market Cap
$1.98B
Shares
535.34M
Volume · Oct 23
19.08M
Avg daily vol (3M)
21.75M
All webcasts
Earnings call · FY2023 Q1
Recursion Pharmaceuticals, Inc. (RXRX) Q1 2023 Earnings Call
Revenue
$12.13M
+127.5% YoY
Diluted EPS
-$0.34
Gross margin · derived Q4
-2.6%
+43.6 pp YoY
Net income
-$65.33M
Research coverage
2 live sources
Open each available source without leaving this research workspace.
Research materials
Open the source you need; every reader stays inside this workspace.
Quarter detail
How the reported period landed and where the business moved.
SEC filing · Item 2.02
8-K earnings release
Filed May 8, 2023 · complete as-filed document
SEC periodic report
10-Q report
Filed May 8, 2023 · complete as-filed document